ArticlePDF Available

Inhibition of Pseudogymnoascus destructans Growth from Conidia and Mycelial Extension by Bacterially Produced Volatile Organic Compounds

Authors:

Abstract and Figures

The recently identified causative agent of white-nose syndrome (WNS), Pseudogymnoascus destructans, has been implicated in the mortality of an estimated 5.5 million North American bats since its initial documentation in 2006 (Frick et al. in Science 329:679-682, 2010). In an effort to identify potential biological and chemical control options for WNS, 6 previously described bacterially produced volatile organic compounds (VOCs) were screened for anti-P. destructans activity. The compounds include decanal; 2-ethyl-1-hexanol; nonanal; benzothiazole; benzaldehyde; andN,N-dimethyloctylamine. P. destructans conidia and mycelial plugs were exposed to the VOCs in a closed air space at 15 and 4 °C and then evaluated for growth inhibition. All VOCs inhibited growth from conidia as well as inhibiting radial mycelial extension, with the greatest effect at 4 °C. Studies of the ecology of fungistatic soils and the natural abundance of the fungistatic VOCs present in these environments suggest a synergistic activity of select VOCs may occur. The evaluation of formulations of two or three VOCs at equivalent concentrations was supportive of synergistic activity in several cases. The identification of bacterially produced VOCs with anti-P. destructans activity indicates disease-suppressive and fungistatic soils as a potentially significant reservoir of biological and chemical control options for WNS and provides wildlife management personnel with tools to combat this devastating disease.
Content may be subject to copyright.
Inhibition of Pseudogymnoascus destructans Growth
from Conidia and Mycelial Extension by Bacterially
Produced Volatile Organic Compounds
Christopher T. Cornelison Kyle T. Gabriel
Courtney Barlament Sidney A. Crow Jr.
Received: 8 August 2013 / Accepted: 22 October 2013 / Published online: 5 November 2013
ÓSpringer Science+Business Media Dordrecht 2013
Abstract The recently identified causative agent of
white-nose syndrome (WNS), Pseudogymnoascus
destructans, has been implicated in the mortality of
an estimated 5.5 million North American bats since its
initial documentation in 2006 (Frick et al. in Science
329:679–682, 2010). In an effort to identify potential
biological and chemical control options for WNS, 6
previously described bacterially produced volatile
organic compounds (VOCs) were screened for anti-
P. destructans activity. The compounds include dec-
anal; 2-ethyl-1-hexanol; nonanal; benzothiazole;
benzaldehyde; andN,N-dimethyloctylamine. P. de-
structans conidia and mycelial plugs were exposed
to the VOCs in a closed air space at 15 and 4 °C and
then evaluated for growth inhibition. All VOCs
inhibited growth from conidia as well as inhibiting
radial mycelial extension, with the greatest effect at
4°C. Studies of the ecology of fungistatic soils and the
natural abundance of the fungistatic VOCs present in
these environments suggest a synergistic activity of
select VOCs may occur. The evaluation of formula-
tions of two or three VOCs at equivalent
concentrations was supportive of synergistic activity
in several cases. The identification of bacterially
produced VOCs with anti-P. destructans activity
indicates disease-suppressive and fungistatic soils as
a potentially significant reservoir of biological and
chemical control options for WNS and provides
wildlife management personnel with tools to combat
this devastating disease.
Keywords Pseudogymnoascus destructans
Mycelia VOC White-nose syndrome
Fungistatsis
Introduction
White-nose syndrome (WNS) was first documented
near Albany, New York, in 2006 [2,15]. Since its
discovery, WNS has caused severe declines in bat
populations in the Eastern United States and Canada
[9,12,23]. Although the exact ecological and
economic impact of this disease has yet to be
determined, many researchers agree that continued
declines in insectivorous bat populations will have a
significant impact on forest management, agriculture
and insect-borne disease [4]. The rapid spread of WNS
and the high mortality rates associated with the disease
[9,13] necessitate the rapid development of disease
management tools. In 2011, the fungus Geomyces
destructans was shown to be the putative causative
agent of WNS [18].
Electronic supplementary material The online version of
this article (doi:10.1007/s11046-013-9716-2) contains supple-
mentary material, which is available to authorized users.
C. T. Cornelison (&)K. T. Gabriel C. Barlament
S. A. Crow Jr.
Applied and Environmental Microbiology, Georgia State
University, 24 Peachtree Center Ave, Atlanta, GA, USA
e-mail: ctcornelison1@gsu.edu
123
Mycopathologia (2014) 177:1–10
DOI 10.1007/s11046-013-9716-2
Recently, the fungus Geomyces destructans has
been reclassified as Pseudogymnoascus destructans
[19,20]. P. destructans is a psychrophilic ascomycete
with optimal growth at 12.5–15.8 °C[15,23]. Its
psychrophilic nature makes P. destructans ideally
suited for colonization of bats in torpor, when body
temperatures and immune function are greatly
depressed [3,5]. The clinical manifestation of P.
destructans infection is characterized by fuzzy white
growth on the muzzle and wings of hibernating bats
and results in severe physical damage to bat wing
membranes [8]. Due to the recent identification of P.
destructans, many ecological and physiological traits
and their influence on virulence are yet to be
elucidated.
The rapid spread and high mortality rates associated
with WNS make the development of in situ treatment
options for P. destructans a significant objective for
wildlife management agencies. Accordingly, the
development of biological and chemical treatment
options is a priority for State and Federal agencies as
stated in the 2011 National WNS Management Plan
established by the United States Fish and Wildlife
Service (USFWS) [1]. With this goal in mind, 6
previously described bacterially produced antifungal
VOCs [7,11] were assayed for their in vitro potential
to inhibit the growth and proliferation of P.
destructans.
Previous investigations of fungistatic soils were
able to identify bacteria that produced antifungal
VOCs which were later identified via SPME/GC/MS
of cultures and soils. The VOCs were produced by
Pseudomonas and Bacillus spp. and demonstrated
broad spectrum antifungal activity [7,11]. Volatile-
based fungistasis in soils has been observed in
terrestrial environments around the globe [25]. Due
to the biological and chemical complexity of these
environments, the ultimate source of the active VOCs
is often unknown but typically attributed to bacteria
[16,25]. The geology and ecology of soil make the
presence of inhibitory volatiles of particular interest,
as low levels of VOCs are able to inhibit fungal growth
in a dense, compartmentalized, and diverse ecosystem
[10,11,14,16]. Using the soil ecosystem as an ideal
example of naturally occurring biological control of
fungal proliferation, we began to investigate biolog-
ically derived VOCs with known antifungal activity.
The influence of the VOCs on the growth from
conidia and mycelial extension of P. destructans was
evaluated using digital imaging techniques. In an
effort to optimize the efficacy of the VOCs for
potential in situ applications, formulations of VOCs
were evaluated for potential synergistic effects. Com-
binations of two VOCs applied at equal quantities as
individual VOCs revealed several potentially syner-
gistic combinations. Accordingly, these synergistic
blends were used to establish formulations of three
VOCs ultimately yielding highly effective formula-
tions with greatly increased anti-Pseudogymnoascus
activity at relative concentrations of \1 ppm. The
identification of biologically produced inhibitory
volatiles expands the pool of potential biocontrol
agents of P. destructans, and the development of
chemical formulations with significant anti-Pseud-
ogymnoascus activity at low concentrations provides
promising chemical control options for in situ man-
agement of WNS.
Materials and Methods
Culture Acquisition and Maintenance
All P. destructans isolates used in the project were
provided by Kevin Keel through his WNS diagnostic
work at the University of Georgia’s Southeastern
Cooperative Wildlife Disease Study (SCWDS). P.
destructans cultures were maintained on Sabauroud
Dextrose Agar (SDA) or in Sabauroud Dextrose Broth
(SDB) (BD, Maryland) at 4–15 °C. P. destructans
spores were stored in phosphate-buffered saline (PBS)
at -20 °C. Spores were stored no longer than 3 weeks
prior to use.
VOC Exposure Assays and Evaluation
of Bacterially Produced VOCs for Anti-P.
destructans Activity
Volatile organic compounds previously shown to be
produced by bacteria [7,11] were screened for anti-P.
destructans activity via VOC exposure to spores and
mycelial plugs. The VOCs included: decanal; 2-ethyl-
1-hexanol; nonanal; benzothiazole; benzaldehyde; and
N,N-dimethyloctylamine (Sigma-Aldrich, Missouri).
All VOCs were chosen based on their identification in
fungistatic soils and their observed production in
bacteria [7,11]. All VOCs purchased as pure, liquid,
research grade reagents and used directly, without
2 Mycopathologia (2014) 177:1–10
123
modification, in all subsequent assays. A single-com-
partment Petri plate (150 mm 915 mm) was used for
a contained airspace to assess P. destructans growth
characteristics in the presence of fungistatic VOCs. Ten
microliters of P. destructans conidia suspension (10
6
conidia ml
-1
in PBS) was spread onto SDA plates
(35 mm 910 mm). Aliquots of 30, 3.0, or 0.3 llof
each VOC corresponding to maximum possible relative
concentrations ranging from 113 ppm (v/v) to
1.13 ppm (v/v) (Table S1) were pipetted onto a sterile
filter paper disk (12.7 mm) on a watch glass (75 mm).
Each VOC containing disk and watch glass was placed
inside a large Petri plate (150 mm 915 mm) along
with a P. destructans-inoculated SDA plate
(35 mm 910 mm) (Fig. 1). P. destructans mycelial
plugs cut from the leading edge of actively growing
colonies were inserted into fresh SDA plates
(35 mm 910 mm) and placed in large Petri plates
(150 mm 915 mm) with each formulation or pure
VOC containing paper disk and sealed with parafilm M
(Sigma-Aldrich, Missouri). Plates were then incubated
at 15 °C for 21 days. Unexposed cultures and the
addition of activated carbon to exposure assays served
as negative controls for each trial. Anti-P. destructans
activity was scored on a plus/minus scale for conidia-
inoculated plates, and the radial growth from mycelial
plugs was used to determine percent inhibition by
comparing growth area of VOC exposed plugs to
unexposed controls. All assays were performed in
triplicate and averaged.
VOC Formulation Assay for Anti-P. destructans
Activity
VOC formulations utilizing combinations of two pure
VOCs were created with all fifteen possible combina-
tions of the six VOCs by applying volumes corre-
sponding to 2.0 lmol of each VOC to separate
absorbent disks and arranging combinations of two
disks of different VOCs on a single watch glass.
Volumes corresponding to 4.0 lmol of each pure VOC
were used as synergism controls to determine syner-
gism. P. destructans mycelial plugs were harvested
and inserted into fresh SDA plates (35 mm 910 mm)
and sealed with parafilm in large Petri plates
(150 mm 915 mm) with each formulation or pure
VOC. Plates were then incubated at 15 °C for 21 days
as described above. Each test was conducted in
triplicate. Area measurements were conducted every
2 days post-inoculation with the use of digital pho-
tography and computer analysis as described below.
Area Measurement of Radial Growth with Digital
Photography and Open-Source Software
Filamentous fungi grow by hyphae elongation and not
by distinct cellular division. Accordingly, measuring
the difference between the area growth of control
agent-exposed mycelial plugs and control plugs has
been a vetted method for assessing antimicrobial
susceptibility [11,17,22]. The use of a ruler to
measure the area of mycelial growth of filamentous
fungi has its own challenges. Mycelial plugs will often
grow asymmetrically, either naturally or because of
exposure to the compound being tested. To provide
more accurate measurement of mycelial growth, a
digital photography and analysis technique was
developed.
The GIMP (GNU Image Manipulation Program) is
open-source, freely distributed software for image
editing and authoring, compatible with GNU/Linux,
Microsoft Windows, Mac OS X, Sun OpenSolaris, and
FreeBSD operating systems. This software allows for
the direct measurement of the number of pixels in a
given selected area of a photograph. GIMP version
2.8.2 for Microsoft Windows was used at the time of
this writing. A Nikon D3100 digital single lens reflex
camera with an 18–55 mm lens was used to capture
images. A standard three-leg tripod was used for
support during capture.
Fig. 1 Shared airspace assay with previously described bacte-
rially produced VOCs
Mycopathologia (2014) 177:1–10 3
123
The camera was attached to the tripod and aimed
down to a surface to provide a consistent distance from
the lens to the mycelial surface being photographed;
ensuring the same pixel to millimeter ratio was
retained for all acquired images. Images of mycelial
plugs had their corresponding image numbers cata-
logued for later identification. All Petri plate agar
heights were similar to ensure the focal point remained
consistent as well as to retain the same pixel to
distance ratio. Manual focus was activated to retain the
same focal point throughout all image captures, and a
remote shutter release device was used to assure
stable, shake-free images were acquired.
Contrast between the growth medium and myce-
lium was required to obtain an accurate selection for
measurement as well as to be able to discern the
margin of the ruler graduation marks with GIMP.
Therefore, the camera’s white balance, exposure,
f-stop, and ISO were adjusted to retain a consistent
contrast between photograph acquisitions. A photo-
graph of a ruler was used to set the focal point for the
proceeding photographs as well as serving as a
calibration device for determining the length of each
pixel during image analysis.
The ruler tool was used to determine the number of
pixels between two demarcations of a photographed
ruler placed at the level of the agar surface in the Petri
plates. The resulting pixel count was used to determine
the millimeter-to-pixel ratio.
A different set of tools were necessary to measure
the mycelial area. The selection tools were used to
outline the margin of the mycelia. The Histogram tool
was used to determine the number of pixels that
comprised the selected area. The area of the selection
was converted from the number of pixels to mm
2
with
our previously derived number of pixels per mm and
Eq. 1.
Number of pixels in are a
Number of pixels per mm

2
= Area of mycelia in mm2
ð1Þ
Tape Mount Preparation and Microscopic
Evaluation
Pseudogymnoascus destructans cultures with aberrant
phenotypes as compared to control cultures and pub-
lished descriptions [14] were examined microscopically
by tape mount. The adhesive side of standard
transparent packaging tape was gently pressed against
the surface ofplate grown fungal colonies. The resulting
tape-adhered sample was treated with 10 llof70%
ethanol and placed onto a microscope slide with
lactophenol cotton blue dye. Slides were viewed on a
light microscope (Nikon optiphot-2) at 200 9magni-
fication and images captured using a scope mounted
camera (QImaging micropublisher 3.3 RTV).
Results
Anti-P. destructans Activity of Bacterially
Produced Volatiles
Initial investigation demonstrated inhibitory activity
for most VOCs at relative concentrations less than
1 ppm. Decanal; 2-ethyl-1-hexanol; nonanal; benzo-
thaizole; dimethyltrisulfide; benzaldehyde; and N,N-
dimethyloctylamine all demonstrated anti-P. destruc-
tans activity when 30 ll of the respective compound
were placed adjacent to SDA plates inoculated with P.
destructans conidia in a closed system at 15 °C
(Table 1). Control plates containing 1 g activated
carbon showed no inhibition for decanal; 2-ethyl-1-
hexanol; and benzaldehyde, while the remaining
compounds inhibitory activity persisted in the pre-
sence of activated carbon (Table 1). Subsequent
assays with 3 ll of each compound demonstrated
similar results with only N,N-dimethyloctylamine
unable to completely inhibit P. destructans growth
from conidia at 7 days (Table 1). The addition of
activated carbon abolished all inhibitory activity of the
assayed compounds at 3 ll (Table 1). At 11 days of
exposure to 3 ll of each respective compound, only
2-ethyl-1-hexanol, decanal, and nonanal demonstrated
inhibitory activity, with all activated carbon controls
abolishing the inhibitory activity (Table 1). Addition-
ally, P. destructans cultures from conidia exposed to
3ll benzothiazole without activated carbon revealed
unique colony morphology characterized by increased
pigmentation of the underside of the culture and
diffusion of pigment into the growth media as
compared to unexposed cultures and cultures exposed
to benzothiazole in the presence of activated carbon
(Fig. S1).
Assays using mycelial plugs cut from the leading
edge of actively growing P. destructans colonies on
SDA exposed to the previously described bacterially
4 Mycopathologia (2014) 177:1–10
123
produced volatiles at 30, 3, and 0.3 ll of each
respective compound and incubated in a contained
air space at 15 °C gave varied results. At 30 ll, all
compounds completely inhibited the growth of P.
destructans mycelia for up to 9 days (Fig. 2a). At
14 days of exposure, only P. destructans plugs
exposed to decanal showed any radial growth, with
83 % reduction in growth as compared to unexposed
controls (Fig. 2a). At 3 ll of each compound, decanal
and N,N-dimethyloctylamine yielded only minor
reductions in radial growth, whereas the remaining
compounds completely inhibited radial mycelial
growth of P. destructans for up to 14 days (Fig. 2b).
At 0.3 ll of each compound, only benzothiazole
demonstrated significant inhibitory activity with a
60 % reduction in radial growth after 14 days of
exposure (Fig. 2c). Interestingly, at 0.3 ll, N,N-
dimethyloctylamine induced growth as compared to
unexposed controls (Fig. 2c). This result may be due
to hormesis [21].
In order to forecast the in situ efficacy of the VOCs
additional in vitro evaluation was conducted at 4 °Cto
more accurately represent the environmental conditions
of North American hibernacula. Exposure to 30 llor
3.0 ll of each respective VOC completely inhibited
radial growth of P. destructans for greater than 21 days
(data not shown). Exposure to 0.3 ll of each respective
VOC inhibited radial growth for all VOCs except
benzaldehyde (Fig. 2d). The greatest degree of inhibi-
tion was observed with decanal which demonstrated a
greater than 99 % reduction in growth area at 35 days
post-inoculation (Fig. 2d). Based on these initial results,
VOC exposure was standardized to 4.0 lmol per
headspace for subsequent evaluations. In addition to
evaluating individual VOCs, formulations were inves-
tigated for potential synergistic effects.
VOC Formulations Demonstrate Synergistic Anti-
P. destructans Activity
Three VOC formulations comprised of two VOCs
were observed to synergistically inhibit the growth of
P. destructans mycelial plugs, more than the com-
bined inhibition of each of the pure VOCs alone.
Table 1 Evaluation of anti-P. destructans activity of bacterially produced antifungal VOCs with P. destructans conidia
VOC Chemical structure 30 ll30ll
c
3ll
a
3ll
a,c
3ll
b
3ll
b,c
2-ethyl-1-hexanol 21 21 21
Benzaldehyde 21 21 11
Benzothiazole 22 21 11
Decanal 21 21 21
Nonanal 22 21 21
N,N-dimethyloctylamine 22 11 11
Control 11 11 11
?, growth from spores; -, no visible growth
a
7 day exposure
b
10 day exposure
c
Incubated with activated carbon
Mycopathologia (2014) 177:1–10 5
123
Those include 2-ethyl-1-hexanol and benzaldehyde;
2-ethyl-1-hexanol and nonanal; 2-ethyl-1-hexanol and
decanal; and 2-ethyl-1-hexanol and N,N-dimethyloc-
tylamine (Fig. 3a, 3b, 3c, respectively). The greatest
inhibition by the formulation occurred with 2-ethyl-1-
hexanol and nonanal, which demonstrated greater than
95 % reduction in growth as compared to unexposed
controls 14 days post-inoculation (Fig. 3c).
Two VOC formulations comprised of three VOCs
at 1.33 lmol, respectively, were observed to syner-
gistically inhibit the growth of P. destructans mycelial
plugs, more than the combined inhibition of each of the
pure VOCs alone at 4.0 lmol. Those include 2-ethyl-
1-hexanol; benzaldehyde; and decanal; as well as
2-ethyl-1-hexanol; nonanal; and decanal (Fig. 4a, 4b).
Discussion
Since its initial documentation in 2006, P. destruc-
tans has spread to twenty-four states and four
Canadian providences and is implicated in the
mortality of 5.5 million bats [13]. Cave closures
and culling of infected individuals appear to have
little to no impact on the spread and mortality
associated with this devastating disease. Classic
disease management practices applied in agriculture
such as broad spectrum dissemination of antibiotics
are not realistic options for management of disease
in wild, highly disseminated, and migratory animal
populations. Accordingly, the development of novel
treatment options is needed to avert the spread of
0.00
20.00
40.00
60.00
80.00
100.00
Area (mm2)
Days post inoculation
a
Control (No VOC)
Decanal
0.00
20.00
40.00
60.00
80.00
100.00
Area (mm2)
Days post inoculation
b
Control (No VOC)
Decanal
N,N-
dimethyloctylamine
0.00
20.00
40.00
60.00
80.00
100.00
120.00
Area (mm2)
Days post inoculation
c
Control (No VOC)
2-ethyl-1-hexanol
Benzaldehyde
Benzothiazole
Decanal
Nonanal
N,N-dimethyloctylamine
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
024681012 024681012
0 2 4 6 8 10 12 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34
Area (mm2)
Days post inoculation
d
Control (No VOC)
2-ethyl-1-hexanol
Benzaldehyde
Benzothiazole
Decanal
Nonanal
N,N-
dimethyloctylamine
Fig. 2 Growth areas of P. destructans mycelial plugs exposed
to bacterially produced VOCs at 15 °Cat30ll(a), 3 ll(b),
0.3 ll(c), respectively. Growth area of mycelial plugs exposed
at 4 °C to 0.3 ll(d) of bacterially produced VOCs. VOCs not
shown in the legend completely inhibited radial growth for the
duration of the experiment
6 Mycopathologia (2014) 177:1–10
123
this disease and reduce the mortality associated with
currently infected hibernacula. To this end, the
evaluation of previously described bacterially pro-
duced antifungal volatiles was conducted to identify
potential chemical control agents as well as identify
potential environmental reservoirs of anti-P. de-
structans activities and expand the pool of potential
biological control agents.
Bacterially derived volatile fungistasis is a well-
documented microbial antagonism and may be com-
mon in terrestrial ecosystems [7,10,11,14,16,25].
Harnessing the potential of these natural antagonisms
is already a powerful tool in the development of highly
effective biological and chemical control options [7,
11,17]. The biological origin of many fungistatic
VOCs lends itself to obtainable inhibitory applications
20.00
40.00
60.00
80.00
100.00
120.00
140.00
160.00
02468101214
Area (mm2)
Days post inoculation
Control
2-ethyl-1-hexanol
Benzaldehyde
2-ethyl-1-hexanol +
Benzaldehyde
a
18.00
38.00
58.00
78.00
98.00
118.00
138.00
Area (mm2)
Days post inoculation
Control
2-ethyl-1-hexanol
Decanal
2-ethyl-1-hexanol + Decanal
b
20.00
40.00
60.00
80.00
100.00
120.00
140.00
02 4 6 8101214
02 4 6 8101214
Area (mm2)
Days post inoculation
Control
2-ethyl-1-hexanol
Nonanal
2-ethyl-1-hexanol + Nonanal
c
Fig. 3 Growth areas of P.
destructans mycelial plugs
exposed to each individual
VOC as well as formulations
at 15 °C. Measurements
taken every 2 days for
14 days. a2-ethyl-1-
hexanol and benzaldehyde,
b2-ethyl-1-hexanol and
decanal, and c2-ethyl-1-
hexanol and nonanal
Mycopathologia (2014) 177:1–10 7
123
due to the typically low level of production in the
natural hosts and the significant antagonistic activity
observed at these low levels [7,10,14,16,21,24]. The
contact-independent activity of antagonistic VOC has
several advantages over topical and oral, contact-
dependent, treatment options that have been shown to
be highly effective at inhibiting the growth of P.
destructans in previous studies [6]. Contact-indepen-
dent antagonisms allow for treatment of many indi-
viduals with a single application and ensure uniform
exposure, avoiding the potential for microbial refugia
on the host that may facilitate re-colonization of the
host once the inhibitory compound has been removed
or degraded. Accordingly, the evaluation of previously
described bacterially produced VOCs reduces the
processing required to identify viable treatment
options, and the contact-independent activity of
antagonistic VOCs has several advantages over topical
and oral antifungal compounds and should be a focus
of studies tasked with identifying novel treatments for
newly emerging fungal diseases.
The coevolution of soil microbiota has produced
antagonisms ideally suited for the complex ecology of
soil. Harnessing these natural antagonisms can be a
powerful tool in combating WNS as many of the traits
of these antagonisms equate favorably with the
ecology of hibernacula and the terrestrial heritage of
the Geomycota and Pseudogymnoascus spp. warrants
their susceptibility. The long-term efficacy of low
quantities of VOCs illustrates the potential of these
compounds for in situ application in the treatment of
WNS. Additionally, the development of synergistic
blends bolsters the appeal of soil-based fungistasis as a
source of potential control agents as VOC mixtures are
likely responsible for the observed fungistatic activity
of repressive soils [14,16,24]. While several pure
VOCs and blends produced significant growth inhibi-
tion, compounds and/or quantities unable to signifi-
cantly inhibit growth caused noteworthy stress to P.
destructans as determined by the abnormal pheno-
types observed under these conditions (Fig. S1). The
evaluation of bacterially derived VOCs has expanded
the pool of potential biological control agents as well
produced several VOC formulations with excellent
anti-Pseudogymnoascus activity. The availability of
volatile formulations for control of P. destructans
15.00
35.00
55.00
75.00
95.00
115.00
135.00
155.00
Area (mm2)
Days Post inoculation
a
Control
2-ethyl-1-hexanol
Benzaldehyde
Decanal
2-ethyl-1-hexanol +
Benzaldehyde +
Decanal
15.00
35.00
55.00
75.00
95.00
115.00
135.00
155.00
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Area (mm2)
Days post inoculation
bControl
2-ethyl-1-hexanol
Nonanal
Decanal
2-ethyl-1-hexanol
+ Nonanal +
Decanal
Fig. 4 Growth areas of P.
destructans mycelial plugs
exposed to each individual
VOC as well as formulations
at 15 °C. Measurements
taken every 2 days for
14 days. a2-ethyl-1-
hexanol; benzaldehyde; and
decanal. b2-ethyl-1-
hexanol; nonanal; and
decanal
8 Mycopathologia (2014) 177:1–10
123
growth could prove to be a powerful tool for wildlife
management agencies if appropriate application meth-
ods can be developed.
Current technology for dissemination of VOCs and
essential oils for control of odors and pests in indoor
environments is common with several companies,
including TimeMist
tm
, Aire-Master
tm
, Prolitec
tm
and
Air-Scent
tm
actively marketing these systems. Manu-
facturers claims vary significantly depending on
product with treatment capacities varying from 6,000
to 50,000 ft
3
for a single unit and maintain 1–10 ppm
concentrations in that area based on timed releases
with various product lines. Although these claims are
promising, appropriate scientific validation is lacking.
Fragrance dispenser systems are compatible with a
wide range of VOC and essential oils and their efficacy
claims warrant further investigation as a potential
application method for anti-Pseudogymnoascus VOCs
in the treatment of WNS in hibernating bats.
The ecology of susceptible bat populations makes
treatment of WNS difficult. The highly dispersed,
difficult to access, and potentially hazardous nature of
bat hibernacula require the development of control
options with persistent inhibitory activity at low
levels. Our results indicate a strong inhibitory activity
for several compounds and have provided valuable
leads for identification of potential biological control
agents. The increased inhibitory effect observed in low
temperature (4 °C) exposures is promising for field
application as they represent a promising duration at
the low temperatures associated with hibernacula
during the time of infection and could have a
significant impact on the mortality associated with
infected hibernacula. Currently, the prognosis for
susceptible North American bat populations is bleak at
best. The development of biological and chemical
treatment options must be investigated to provide
wildlife management agencies with tools for control of
P. destructans transmission and infectivity.
This project identified biologically derived chem-
ical control agents that can potentially disrupt trans-
mission by inhibiting growth from conidia as well as
decrease infection/mortality rates in hibernacula cur-
rently infected with P. destructans. Additionally,
several of the compounds evaluated in this study have
the potential for application in captive-recovery
programs purposed in the National Response Plan
[1]. Cumulatively, this study has highlighted potential
control options for further investigation for
application in management of WNS as well as
identified fungistatic soils as a potentially significant
reservoir of biological control agents.
Acknowledgments This work was funded by the Georgia State
University Department of Biology, as well as the Georgia State
University Environmental Research Program. The authors would
like to thank Kevin Keel for providing the fungal cultures used in
this study. The authors would also like to thank Ian Sarad, Blake
Cherney, and Ben Poodiak for their contributions to this effort.
References
1. Ballman A, Benedict L, Britzke E, Castle K, Cottrell W,
Cryan P, DeLiberto T, Elliot A, Ewing R, Hicks A, Rey-
nolds R, Rubado J, Slack B, Williams L, Coleman J. A
national plan for assisting states, federal agencies, and tribes
in managing white-nose syndrome in bats. 2011:
whitenosesyndrom.org.
2. Blehert DS, Hicks AC, Behr M. Bat white-nose syndrome:
an emerging fungal pathogen? Science. 2008;323:227.
3. Boyles JG, Willis C. Could localized warm areas inside cold
caves reduce mortality of hibernating bats affected by
white-nose syndrome? Front Ecol Environ. 2010;8:92–8.
4. Boyles JG, Cryan PM, McCracken GF, Kunz TH. Economic
importance of bats in agriculture. Science. 2011;332:41–2.
5. Casadevall A. Fungal virulence, vertebrate endothermy, and
dinosaur extinction: is there a connection? Fungal Genet
Biol. 2005;42:98–106.
6. Chaturvedi S, Rajkumar SS, Li X, Hurteau GJ, Shtutman M,
Chaturvedi V. Antifungal testing and high-throughput
screening of compound library against Geomyces destruc-
tans, the etiologic agent of Geomycosis (WNS) in bats. PLoS
ONE. 2011;6:e17032. doi:10.1371/journal.pone.0017032.
7. Chuankun X, Minghe M, Leming Z, Keqin Z. Soil volatile
fungistasis and volatile fungistatic compounds. Soil Biol
Biochem. 2004;36:1997–2004.
8. Cryan P, Meteyer CU, Boyles J, Blehert DS. Wing pathol-
ogy of white-nose syndrome in bats suggests life threatening
disruption of physiology. BMC Biol. 2010;8:135.
9. Cryan P. White-nose syndrome threatens the survival of
hibernating bats in North America. In: USGS Fort Collins
Science Center. 2011. Retrieved 21 Apr 2012.
10. Ezra D, Strobel GA. Effect of substrate on the bioactivity of
volatile antimicrobials produced by Muscodor albus. Plant
Sci. 2003;165:1229–38.
11. Fernando WGD, Ramarathnam R, Krishnamoorthy AS,
Savchuk SC. Identification and use of potential bacterial
organic antifungal volatiles in biocontrol. Soil Biol Bio-
chem. 2005;37:955–64.
12. Frick WF, Pollock JF,Hicks AC, Langwig KE, Reynolds DS,
Turner GG, Butchkoski CM, Kunz TH. An emerging disease
causes regional population collapse of a common North
American bat species. Science. 2010;329:679–82.
13. Froschauer A, Coleman J. North American bat death toll
exceeds 5.5 million from white-nose syndrome. U.S. Fish
and Wildlife Service; 2012. http://www.batcon.org/pdfs/
USFWS_WNS_Mortality_2012_NR_FINAL.pdf
Mycopathologia (2014) 177:1–10 9
123
14. Garbeva P, Hol WHG, Termorshuizen AJ, Kowalchuk GA,
Boer WD. Fungistasis and general soil biostasis—a new
synthesis. Soil Biol Biochem. 2001;43:469–77.
15. Gargas A, Trest MT, Christensen M, Volk TJ, Blehert DS.
Geomyces destructans sp. nov., associated with bat white-
nose syndrome. Mycotaxon. 2009;108:147–54.
16. Kerr JR. Bacterial inhibition of fungal growth and patho-
genicity. Microb Ecol Health Dis. 1999;11:129–42.
17. Liu W, Mu W, Zhu B, Liu F. Antifungal activities and
components of VOCs produced by Bacillus subtilis G
8
. Curr
Res Bacteriol. 2008;1:128–34.
18. Lorch JM, Meteyer CU, Boyles JG, Cryan P, Hicks AC,
Ballman AE, Coleman JTH, Redell DN, Reeder DM, Ble-
hert DS. Experimental infection of bats with Geomyces
destructans causes white-nose syndrome. Nature.
2011;480:376–8.
19. Lorch JM, Lindner DL, Gargas A, Muller LK, Minnis AM,
Blehert DS. A culture-based survey of fungi in soil from bat
hibernacula in the eastern United States and its implications
for detection of Geomyces destructans, the causal agent of
bat white-nose syndrome. Mycologia. 2013;105:237–52.
20. Minnis AM, Linder DL. Phyloge netic evaluation of Geomyces
and allies reveals no close relatives of Pseudogymnoascus
destructans, comb. nov., in bat hibernacula of eastern North
America. Fungal Biol. 2013. http://dx.doi.org/10.1016/j.
funbio.2013.07.001.
21. Stebbing ARD. Hormesis: the stimulation of growth by low
levels of inhibitors. Sci Total Environ. 1982;22:213–34.
22. Strobel GA, Kluck K, Hess WM, Sears J, Ezra D, Vargas PN.
Muscodor albus E-6, an endophyte of Guazuma ulmifolia
making volatile antibiotics: isolation, characterization and
experimental establishment in the host plant. Microbiology.
2007;153:2613–20.
23. Turner GG, Reeder DM, Coleman JTH. A five-year
assessment of mortality and geographic spread of white-
nose syndrome in North American bats and a look to the
future. Bat Res News. 2011;52:13–27.
24. Verant ML, Boyles JG, Waldrep W, Wibbelt G, Blehert DS.
Temperature-dependent growth of Geomyces destructans,
the fungus that causes bat white-nose syndrome. PLoS
ONE. 2012;7:e46280. doi:10.1371/journal.pone.0046280.
25. Zou CS, Mo ME, Gu YQ, Zhou JP, Zhang KQ. Possible
contributions of volatile-producing bacteria to soil fungi-
stasis. Soil Biol Biochem. 2007;39:2371–9.
10 Mycopathologia (2014) 177:1–10
123
... A number of potential mitigation methods have been developed or experimentally tested against P. destructans or treating white-nose syndrome, including chemical agents [14][15][16][17][18][19][20], microbial antagonists [21][22][23][24][25][26][27], environmental modulation [28,29], UV light exposure [30][31][32], antibiotics [33], vaccination [34], and electrolyte supplementation [35], among others. Of these, the greatest interest has been in the use of chemical and microbial agents to inhibit the growth and pathogenicity of P. destructans. ...
... Our early investigations demonstrated the ability of a ubiquitous soil-dwelling bacterium, Rhodococcus Rhodochrous strain DAP 96253, to inhibit the growth of several fungal pathogens and spoilage organisms, including P. destructans, when placed in a shared airspace with the target organism [22,45]. Further investigations utilizing antimicrobial VOCs demonstrated the feasibility of their use in vitro to suppress P. destructans conidia germination and mycelial growth [14]. The low inhibitory concentrations observed with select VOCs suggested a potential to utilize these compounds in novel ways to combat undesired microbial growth and infection. ...
... Several antimicrobial susceptibility assays with synthetically-produced chemicals and formulations were conducted previously in order to discover novel antagonistic and synergistic effects against P. destructans using aliquots of VOCs dispensed on absorbent discs and sealed in a shared airspace with P. destructans-inoculated media [14]. ...
Article
Full-text available
Pseudogymnoascus destructans is a fungal pathogen responsible for a deadly disease among North American bats known as white-nose syndrome (WNS). Since detection of WNS in the United States in 2006, its rapid spread and high mortality has challenged development of treatment and prevention methods, a significant objective for wildlife management agencies. In an effort to mitigate precipitous declines in bat populations due to WNS, we have developed and implemented a multi-year mitigation strategy at Black Diamond Tunnel (BDT), Georgia, singly known as one of the most substantial winter colony sites for tricolored bats (Perimyotis subflavus), with pre-WNS abundance exceeding 5000 individuals. Our mitigation approach involved in situ treatment of bats at the colony level through aerosol distribution of antifungal volatile organic compounds (VOCs) that demonstrated an in vitro ability to inhibit P. destructans conidia germination and mycelial growth through contact-independent exposure. The VOCs evaluated have been identified from microbes inhabiting naturally-occurring fungistatic soils and endophytic fungi. These VOCs are of low toxicity to mammals and have been observed to elicit antagonism of P. destructans at low gaseous concentrations. Cumulatively, our observations resolved no detrimental impact on bat behavior or health, yet indicated a potential for attenuation of WNS related declines at BDT and demonstrated the feasibility of this novel disease management approach.
... Skin-dwelling symbionts can protect the host by healing wounds (Di Domizio et al., 2020), competing with the pathogen for space and nutrients, or even by directly killing the pathogen (Cogen et al., 2010;O'Neill et al., 2020). Various mutualistic microbes are able to secrete antifungal agents, such as volatile organic compounds (Grice & Segre, 2011), many of which inhibit the growth of P. destructans (Cornelison et al., 2014;Micalizzi & Smith, 2020;Padhi et al., 2018). The mere presence of known antifungal taxa found on the skin of bats can inhibit the growth of P. destructans both in vitro (Cornelison et al., 2014;Forsythe et al., 2022;Fritze et al., 2012;Grisnik et al., 2020;Hamm et al., 2017;Hoyt et al., 2015) and in vivo Hoyt et al., 2019). ...
... Various mutualistic microbes are able to secrete antifungal agents, such as volatile organic compounds (Grice & Segre, 2011), many of which inhibit the growth of P. destructans (Cornelison et al., 2014;Micalizzi & Smith, 2020;Padhi et al., 2018). The mere presence of known antifungal taxa found on the skin of bats can inhibit the growth of P. destructans both in vitro (Cornelison et al., 2014;Forsythe et al., 2022;Fritze et al., 2012;Grisnik et al., 2020;Hamm et al., 2017;Hoyt et al., 2015) and in vivo Hoyt et al., 2019). Surprisingly, only 7 studies have been conducted on the protective skin microbiome in Palearctic bats so far, leaving a major part of the puzzle contributing to survival unaddressed (Troitsky et al., 2023). ...
Article
The fungal infection causing white‐nose disease in hibernating bats in North America has resulted in dramatic population declines of affected species, since the introduction of the causative agent Pseudogymnoascus destructans . The fungus is native to the Palearctic, where it also infects several bat species, yet rarely causes severe pathology or the death of the host. Pseudogymnoascus destructans infects bats during hibernation by invading and digesting the skin tissue, resulting in the disruption of torpor patterns and consequent emaciation. Relations among pathogen, host, and environment are complex, and individuals, populations, and species respond to the fungal pathogen in different ways. For example, the Nearctic Myotis lucifugus responds to infection by mounting a robust immune response, leading to immunopathology often contributing to mortality. In contrast, the Palearctic M. myotis shows no significant immunological response to infection. This lack of a strong response, resulting from the long coevolution between the hosts and the pathogen in the pathogen's native range, likely contributes to survival in tolerant species. After more than 15 years since the initial introduction of the fungus to North America, some of the affected populations are showing signs of recovery, suggesting that the fungus, hosts, or both are undergoing processes that may eventually lead to coexistence. The suggested or implemented management methods of the disease in North America have encompassed, for example, the use of probiotics and fungicides, vaccinations, and modifying the environmental conditions of the hibernation sites to limit the growth of the pathogen, intensity of infection, or the hosts’ responses to it. Based on current knowledge from Eurasia, policy makers and conservation managers should refrain from disrupting the ongoing evolutionary processes and adopt a holistic approach to managing the epizootic.
... Alternatives include active (power washing or targeted spraying) or passive removal through chemical and chemical-free inactivation (PEG, VOCs or UV sterilization Cornelison et al., 2014, Palmer et al., 2018. Alternative treatments should consider effectiveness in reaching large portions of the site, effectiveness underground and scalability. ...
Article
Full-text available
Emerging infectious diseases have caused population declines and biodiversity loss. The ability of pathogens to survive in the environment, independent of their host, can exacerbate disease impacts and increase the likelihood of species extinction. Control of pathogens with environmental stages remains a significant challenge for conservation and effective management strategies are urgently needed. We examined the effectiveness of managing environmental exposure to reduce the impacts of an emerging infectious disease of bats, white‐nose syndrome (WNS). We used a chemical disinfectant, chlorine dioxide (ClO2), to experimentally reduce Pseudogymnoascus destructans, the fungal pathogen causing WNS, in the environment. We combined laboratory experiments with 3 years of field trials at four abandoned mines to determine whether ClO2 could effectively remove P. destructans from the environment, reduce host infection and limit population impacts. ClO2 was effective at killing P. destructans in vitro across multiple concentrations. In field settings, higher concentrations of ClO2 treatment were needed to sufficiently reduce viable P. destructans conidia in the environment. The reduction in the environmental reservoir at treatment sites resulted in lower fungal loads on bats compared to untreated control populations. Survival following treatment was also higher in little brown bats (Myotis lucifugus), and trended higher for tricolored bats (Perimyotis subflavus). Synthesis and applications. Our results highlight that targeted management of sources for environmental transmission can be an effective control strategy for wildlife disease. We found that successfully reducing pathogen in the environment decreased disease severity and increased survival, but required higher treatment exposure than was effective in laboratory experiments, and the effects varied among species. More broadly, our findings have implications for other emerging wildlife diseases with free‐living pathogen stages by highlighting how the degree of environmental contamination can have cascading impacts on hosts, presenting an opportunity for intervention.
Article
Full-text available
Symbiotic microorganisms that reside on the host skin serve as the primary defense against pathogens in vertebrates. Specifically, the skin microbiome of bats may play a crucial role in providing resistance against Pseudogymnoascus destructans (Pd), the pathogen causing white-nose syndrome. However, the epidermis symbiotic microbiome and its specific role in resisting Pd in highly resistant bats in Asia are still not well understood. In this study, we collected and characterized skin microbiota samples of 19 Myotis pilosus in China and explored the differences between Pd-positive and negative individuals. We identified inhibitory effects of these bacteria through cultivation methods. Our results revealed that the Simpson diversity index of the skin microbiota for positive individuals was significantly lower than that of negative individuals, and the relative abundance of Pseudomonas was significantly higher in positive bats. Regardless of whether individuals were positive or negative for Pd, the relative abundance of potentially antifungal genera in skin microbiota was high. Moreover, we successfully isolated 165 microbes from bat skin and 41 isolates from positive individuals able to inhibit Pd growth compared to only 12 isolates from negative individuals. A total of 10 genera of Pd-inhibiting bacteria were screened, among which the genera Algoriella, Glutamicibacter, and Psychrobacter were newly discovered as Pd-inhibiting genera. These Pd-inhibiting bacteria metabolized a variety of volatile compounds, including dimethyl trisulfide, dimethyl disulfide, propylene sulfide, 2-undecanone, and 2-nonanone, which were able to completely inhibit Pd growth at low concentrations. IMPORTANCE Recently, white-nose syndrome has caused the deaths of millions of hibernating bats, even threatening some with regional extinction. Bats in China with high resistance to Pseudogymnoascus destructans can provide a powerful reference for studying the management of white-nose syndrome and understanding the bats against the pathogen’s intrinsic mechanisms. This study sheds light on the crucial role of host symbiotic skin microorganisms in resistance to pathogenic fungi and highlights the potential for harnessing natural defense mechanisms for the prevention and treatment of white-nose syndrome. In addition, this may also provide promising candidates for the development of bioinsecticides and fungicides that offer new avenues for addressing fungal diseases in wildlife and agricultural environments.
Article
Full-text available
Bats are widespread mammals that play key roles in ecosystems as pollinators and insectivores. However, there is a paucity of information about bat-associated microbes, in particular their fungal communities, despite the important role microbes play in host health and overall host function. The emerging fungal disease, white-nose syndrome, presents a potential challenge to the bat microbiome and understanding healthy bat-associated taxa will provide valuable information about potential microbiome-pathogen interactions. To address this knowledge gap, we collected 174 bat fur/skin swabs from 14 species of bats captured in five locations in New Mexico and Arizona and used high-throughput sequencing of the fungal internal transcribed (ITS) region to characterize bat-associated fungal communities. Our results revealed a highly heterogeneous bat mycobiome that was structured by geography and bat species. Furthermore, our data suggest that bat-associated fungal communities are affected by bat foraging, indicating the bat skin microbiota is dynamic on short time scales. Finally, despite the strong effects of site and species, we found widespread and abundant taxa from several taxonomic groups including the genera Alternaria and Metschnikowia that have the potential to be inhibitory towards fungal and bacterial pathogens.
Article
This datasheet on Pseudogymnoascus destructans covers Identity, Overview, Distribution, Dispersal, Hosts/Species Affected, Environmental Requirements, Impacts, Further Information.
Article
This datasheet on Infection with Pseudogymnoascus destructans in bats covers Identity, Overview, Associated Diseases, Pests or Pathogens, Distribution, Hosts/Species Affected, Diagnosis, Pathology, Epidemiology, Impacts, Prevention/Control, Further Information.
Preprint
Full-text available
Bats are widespread mammals that play key roles in ecosystems as pollinators and insectivores. However, there is a paucity of information about bat-associated microbes, in particular their fungal communities, despite the important role microbes play in host health and overall host function. The emerging fungal disease, white-nose syndrome, presents a potential challenge to the bat microbiome and understanding healthy bat-associated taxa will provide valuable information about potential microbiome-pathogen interactions. To address this knowledge gap, we collected 174 bat fur/skin swabs from 14 species of bats captured in five locations in New Mexico and Arizona and used high-throughput sequencing of the fungal internal transcribed (ITS) region to characterize bat-associated fungal communities. Our results revealed a highly heterogeneous bat mycobiome that was structured by geography and bat species. Furthermore, our data suggest that bat-associated fungal communities are affected by bat foraging, indicating the bat skin microbiota is dynamic on short time scales. Finally, despite the strong effects of site and species, we found widespread and abundant taxa from several taxonomic groups including the genera Alternaria and Metschnikowia that have the potential to be inhibitory towards fungal and bacterial pathogens.
Preprint
Emerging infectious diseases are a serious threat to wildlife communities, and the ability of pathogens to survive in the environment can exacerbate disease impacts on hosts and increase the likelihood of species extinction. Targeted removal or control of these environmental reservoirs could provide an effective mitigation strategy for reducing disease impacts but is rarely used in wildlife disease control. We examined the effectiveness of managing environmental transmission to reduce impacts of an emerging infectious disease of bats, white-nose syndrome. We used a chemical disinfectant, chlorine dioxide (ClO 2 ), to experimentally reduce Pseudogymnoascus destructans , the fungal pathogen causing WNS, in the environment. We conducted laboratory experiments followed by three years of field trials at four abandoned mines to determine whether ClO 2 could effectively reduce P. destructans in the environment, reduce host infection, and limit population impacts. ClO 2 was effective at killing P. destructans in vitro across a range of concentrations. In field settings, higher concentrations of ClO 2 treatment sufficiently reduced viable P. destructans conidia in the environment. The reduction in the environmental reservoir at treatment sites resulted in lower fungal loads on bats compared to untreated control populations. Survival following treatment was higher in little brown bats ( Myotis lucifugus ), and trended higher for tricolored bats ( Perimyotis subflavus ) compared to untreated sites. These findings support the management of environmental reservoirs as an effective control strategy for wildlife disease and provide a valuable tool for ongoing conservation efforts. More broadly, these results highlight how the intensity of environmental reservoirs can have cascading impacts on host infection and population declines.
Article
Full-text available
White-nose syndrome (WNS) is a disease responsible for unprecedented mortality in hibernating bats in the northeastern U.S. This previously unrecognized disease has spread very rapidly since its discovery in January 2007, and poses a considerable threat to hibernating bats throughout North America. As WNS spreads, the challenges for understanding and managing the disease continue to increase. Given the escalating complexity of these challenges, a highly coordinated effort is required for State, Federal, and Tribal wildlife agencies, and private partners to respond effectively to WNS and conserve species of bats. The plan proposed herein details the elements that are critical to the investigation and management of WNS, identifies key action items to address stated goals, and outlines the role(s) of agencies and entities involved in this continental effort.
Article
Full-text available
The presence of an unusual fungal infection and aberrant behavior in hibernating bats was first described in New York during winter 2006–2007. The disease was dubbed white-nose syndrome (WNS) after the most prominent field sign—white fungus on the muzzle and other areas of exposed skin. The fungus, newly described as Geomyces destructans, also produces characteristic skin lesions on the wing and other membranes of bats (Blehert et al. 2009; Courtin et al., 2010; Meteyer et al., 2009) and probably is the causative agent of the disease (Blehert et al. 2009; Gargas et al. 2009). In this review, we briefly summarize the current state of knowledge, including estimates of mortality for a five-state region, and describe a national plan for managing WNS. Our report is not meant to be a comprehensive review of the ever-expanding literature, but we do include a bibliography of peer-reviewed publications concerning WNS.
Article
Full-text available
White-nose syndrome (WNS) of bats, caused by the fungus previously known as Geomyces destructans, has decimated populations of insectivorous bats in eastern North America. Recent work on fungi associated with bat hibernacula uncovered a large number of species of Geomyces and allies, far exceeding the number of described species. Communication about these species has been hindered by the lack of a modern taxonomic evaluation, and a phylogenetic framework of the group is needed to understand the origin of G. destructans and to target closely related species and their genomes for the purposes of understanding mechanisms of pathogenicity. We addressed these issues by generating DNA sequence data for the internal transcribed spacer (ITS) region, nuclear large subunit (LSU) rDNA, MCM7, RPB2, and TEF1 from a diverse array of Geomyces and allies that included isolates recovered from bat hibernacula as well as those that represent important type species. Phylogenetic analyses indicate Geomyces and allies should be classified in the family Pseudeurotiaceae, and the genera Geomyces, Gymnostellatospora, and Pseudogymnoascus should be recognized as distinct. True Geomyces are restricted to a basal lineage based on phylogenetic placement of the type species, Geomyces auratus. Thus, G. destructans is placed in genus Pseudogymnoascus. The closest relatives of Pseudogymnoascus destructans are members of the Pseudogymnoascus roseus species complex, however, the isolated and long branch of P. destructans indicates that none of the species included in this study are closely related, thus providing further support to the hypothesis that this pathogen is non-native and invasive in eastern North America. Several conidia-producing isolates from bat hibernacula previously identified as members of Pseudeurotium are determined to belong to the genus Leuconeurospora, which is widespread, especially in colder regions. Teberdinia hygrophila is transferred to Pseudeurotium as Pseudeurotium hygrophilum, comb. nov., in accordance with the one name per fungus system of classification, and two additional combinations are made in Pseudogymnoascus including Pseudogymnoascus carnis and Pseudogymnoascus pannorum. Additional sampling from other regions of the world is needed to better understand the evolution and biogeography of this important and diverse group of fungi.
Article
Full-text available
We describe and illustrate the new species Geomyces destructans. Bats infected with this fungus present with powdery conidia and hyphae on their muzzles, wing membranes, and/or pinnae, leading to description of the accompanying disease as white-nose syndrome, a cause of widespread mortality among hibernating bats in the northeastern US. Based on rRNA gene sequence (ITS and SSU) characters the fungus is placed in the genus Geomyces, yet its distinctive asymmetrically curved conidia are unlike those of any described Geomyces species.
Article
Full-text available
The recent emergence of white-nose syndrome (WNS), a fungal disease causing unprecedented mortality among hibernating bats of eastern North America, has revealed a knowledge gap regarding fungal communities associated with bats and their hibernacula. We used culture-based techniques to investigate the diversity of fungi in soil samples collected from 24 bat hibernacula in the eastern United States. Ribosomal RNA regions (internal transcribed spacer and partial intergenic spacer) were sequenced to preliminarily characterize isolates. Geomyces species were one of the most abundant and diverse groups cultured, representing approximately 33% of all isolates. Geomyces destructans was isolated from soil samples from three hibernacula in states where WNS is known to occur, and many of the other cultured Geomyces isolates likely represent undescribed taxa. Further characterization of the diversity of fungi that occur in hibernacula will both facilitate an improved understanding of the ecology of G. destructans within this complex fungal community and provide an opportunity to identify characteristics that differentiate G. destructans from non-pathogenic relatives.
Article
Full-text available
White-nose syndrome (WNS) is an emergent disease estimated to have killed over five million North American bats. Caused by the psychrophilic fungus Geomyces destructans, WNS specifically affects bats during hibernation. We describe temperature-dependent growth performance and morphology for six independent isolates of G. destructans from North America and Europe. Thermal performance curves for all isolates displayed an intermediate peak with rapid decline in performance above the peak. Optimal temperatures for growth were between 12.5 and 15.8°C, and the upper critical temperature for growth was between 19.0 and 19.8°C. Growth rates varied across isolates, irrespective of geographic origin, and above 12°C all isolates displayed atypical morphology that may have implications for proliferation of the fungus. This study demonstrates that small variations in temperature, consistent with those inherent of bat hibernacula, affect growth performance and physiology of G. destructans, which may influence temperature-dependent progression and severity of WNS in wild bats.
Article
Antifungal activity has been detected in many bacterial genera, both saprophytes and human pathogens, including Actinomadura, Actinoplanes, Arthrobacter, Micromonospora, Streptomyces, Nocardia, Mycobacterium, Aureobacterium, Bacillus, Bre6ibacterium, Lactobacillus, Rhodococcus, Micrococcus, Streptococcus, Enterococcus, Escherichia, Proteus, Klebsiella, Enterobacter, Serratia, Pseudomonas, Burkholderia, Stenotrophomonas, Agrobacterium, Alcaligenes, Azotobacter, Clostridium and Fusobacterium . A variety of methods have been used to detect this activity in vitro . Presumably, this activity confers an ecological advantage on a bacterial population which competes with other species in a particular habitat. The significance of this activity includes the following. First, development of therapeutic antifungal drugs. Second, development of plant protection agents. Third, fungal growth inhibition within the human body in sites with a normal flora with effects on the pathogenesis and course of human infection. Fourth, inhibition of pathogenic fungi in human clinical specimens, reducing the likelihood of in vitro culture of fungi.
Article
White-nose syndrome (WNS) is a mysterious condition affecting populations of hibernating bats in the northeastern US. Little is known about its physiological effects on bats and no intervention has so far been proposed to slow associated mortality. We use an individual-based population model to examine how disruption of normal hibernation or pre-hibernation physiology could lead to the pattern of mortality that has been observed. We present evidence that artificial warming of localized areas within hibernacula could increase survival of WNS-affected bats during winter by lessening the energetic costs of periodic arousals. The model suggests that localized thermal refugia of 28°C could improve survival by up to 75%, depending on how WNS acts to disrupt energy balance. This approach has yet to be tested, but it could serve as a stop-gap measure to slow population declines until a solution is found, or to preserve remnant bat populations if WNS becomes ubiquitous throughout the ranges of affected species.
Article
Antifungal activity has been detected in many bacterial genera, both saprophytes and human pathogens, including Actinomadura, Actinoplanes, Arthrobacter, Micromonospora, Streptomyces, Nocardia, Mycobacterium, Aureobacterium, Bacillus, Brevibacterium, Lactobacillus, Rhodococcus, Micrococcus, Streptococcus, Enterococcus, Escherichia, Proteus, Klebsiella, Enterobacter, Serratia, Pseudomonas, Burkholderia, Stenotrophomonas, Agrobacterium, Alcaligenes, Azotobacter, Clostridium and Fusobacterium. A variety of methods have been used to detect this activity in vitro. Presumably, this activity confers an ecological advantage on a bacterial population which competes with other species in a particular habitat. The significance of this activity includes the following. First, development of therapeutic antifungal drugs. Second, development of plant protection agents. Third, fungal growth inhibition within the human body in sites with a normal flora with effects on the pathogenesis and course of human infection. Fourth, inhibition of pathogenic fungi in human clinical specimens, reducing the likelihood of in vitro culture of fungi.